leukocyte disorder
leukocyte disorder
Explore linked clinical trials. Standard reference: MONDO:0004805204 results ยท Page 1 of 9
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States | Deglutition Disorders, Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Pharyngeal Diseases, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-10-09 | NCT07027826 | |
| Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, chronic granulomatous disease, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, phagocyte bactericidal dysfunction | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT05463133 | |
| Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, chronic granulomatous disease, graft versus host disease, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, phagocyte bactericidal dysfunction | Active, not recruiting | Early phase 1 | 2026-10-08 | NCT03910452 | |
| Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia | Bacterial Infections and Mycoses, Central Nervous System Fungal Infections, Cryptococcal meningitis, Cytopenia, DNA Virus Infections, Hemic and Lymphatic Diseases, Infections, Neuroinflammatory Diseases, Opportunistic Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, autoimmune disease, central nervous system disorder, central nervous system infectious disorder, common wart, cryptococcosis, fungal infectious disease, fungal meningitis, hematologic disorder, human papilloma virus infection, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia, meningitis, nervous system disorder, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Not stated | 2026-10-08 | NCT00867269 | |
| Screening for Hematology Branch Protocols | Cytopenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, agranulocytosis, anemia, blood platelet disease, disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia, thrombocytopenia | Enrolling by invitation | Not stated | 2026-10-08 | NCT00001620 | |
| Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Granuloma, Hemic and Lymphatic Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, chronic granulomatous disease, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, phagocyte bactericidal dysfunction | Recruiting | Not stated | 2026-10-08 | NCT00001405 | |
| A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis | Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07588568 | |
| A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07323654 | |
| Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection | DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, infectious mononucleosis, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, viral infectious disease | Recruiting | Phase 1 | 2026-10-06 | NCT06908096 | |
| Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder | Recruiting | Phase 2 | 2026-10-06 | NCT06477653 | |
| NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD) | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hemic and Lymphatic Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Primary Immunodeficiency Diseases, Toxemia, X-linked disease, chronic granulomatous disease, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, phagocyte bactericidal dysfunction | Recruiting | Phase 1 | 2026-10-02 | NCT05189925 | |
| Natural History and Genetics of Food Allergy and Related Conditions | Abnormalities, Multiple, Aneurysm, Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Loeys-Dietz syndrome, Musculoskeletal Abnormalities, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, aortic aneurysm, aortic disorder, atopic eczema, bone disorder, cardiovascular disorder, dermatitis, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, food allergy, gastroenteritis, hematologic disorder, hereditary disease, hereditary skin disorder, immune system disorder, leukocyte disorder, musculoskeletal system disorder, osteochondrodysplasia, skin disorder, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT02504853 | |
| Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus | Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT02202590 | |
| A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) | Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Active, not recruiting | Phase 4 | 2026-09-30 | NCT06101095 | |
| A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis | Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Recruiting | Phase 3 | 2026-09-29 | NCT07112378 | |
| A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-09-29 | NCT05692180 | |
| the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer | Cytopenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, agranulocytosis, breast cancer, breast disorder, breast neoplasm, hematologic disorder, leukocyte disorder, leukopenia, neoplasm, neutropenia, skin disorder | Recruiting | Phase 2 | 2026-09-28 | NCT07380646 | |
| Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe) | Cytopenia, Hemic and Lymphatic Diseases, autoimmune disease, hematologic disorder, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia | Recruiting | Phase 1 | 2026-09-28 | NCT04097561 | |
| Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Primary Immunodeficiency Diseases, hematologic disorder, hereditary disease, hyper-IgE recurrent infection syndrome 1, autosomal dominant, immune system disorder, inborn error of immunity, leukocyte disorder, phagocyte bactericidal dysfunction | Active, not recruiting | Phase 2 | 2026-09-28 | NCT01176006 | |
| Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infections, Primary Immunodeficiency Diseases, hematologic disorder, hereditary disease, hyper-IgE recurrent infection syndrome 1, autosomal dominant, immune system disorder, inborn error of immunity, leukocyte disorder, lung disorder, phagocyte bactericidal dysfunction, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-09-28 | NCT00006150 | |
| Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, asthma, bronchial disorder, helminthiasis, hematologic disorder, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, parasitic infectious disease, respiratory system disorder | Recruiting | Not stated | 2026-09-28 | NCT00001406 | |
| Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy | Blood Protein Disorders, Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, agranulocytosis, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukocyte disorder, leukopenia, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, neutropenia, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07842198 | |
| Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 4 | 2026-09-25 | NCT03953300 | |
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma | Bacterial Infections and Mycoses, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, pulmonary aspergilloma, pulmonary eosinophilia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2026-09-24 | NCT07828327 | |
| Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not applicable | 2026-09-24 | NCT07372131 |